Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Secrest

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Current Medical Research and Opinion|February 8, 2008
Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosisAlan L Burshell, Jingli Song, Sherie A Dowsett, et al.
Journal of the National Cancer Institute|December 2, 2004
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifeneSilvana Martino, Jane A Cauley, Elizabeth Barrett-Connor, et al.
The Journal of Sexual Medicine|October 11, 2011
Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind studyRussell Blair Egerdie, Stephen Auerbach, Claus G Roehrborn, et al.
American Journal of Obstetrics and Gynecology|February 20, 2003
Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal womenValerie P Jackson, Javier A San Martin, Roberta J Secrest, et al.
Journal of Patient-Reported Outcomes|November 1, 2019
A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitisLouise Newton, Jason A Randall, Theresa Hunter, et al.
Lower Urinary Tract Symptoms|December 18, 2015
Tadalafil Administered Once Daily for Treatment of Lower Urinary Tract Symptoms in Korean men with Benign Prostatic Hyperplasia: Results from a Placebo-Controlled Pilot Study Using Tamsulosin as an Active ControlSae Chul Kim, Jong Kwan Park, Sae Woong Kim, et al.
Lancet (London, England)|June 15, 2015
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trialsChristopher E M Griffiths, Kristian Reich, Mark Lebwohl, et al.
The New England Journal of Medicine|June 15, 2016
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque PsoriasisKenneth B Gordon, Andrew Blauvelt, Kim A Papp, et al.
Physical Review Letters|October 26, 2005
Q2 dependence of the neutron spin structure function g2(n) at low Q2K Kramer, D S Armstrong, T D Averett, et al.
Physical Review Letters|October 13, 2007
Transverse beam spin asymmetries in forward-angle elastic electron-proton scatteringD S Armstrong, J Arvieux, R Asaturyan, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Current Medical Research and Opinion|February 8, 2008
Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosisAlan L Burshell, Jingli Song, Sherie A Dowsett, et al.
Journal of the National Cancer Institute|December 2, 2004
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifeneSilvana Martino, Jane A Cauley, Elizabeth Barrett-Connor, et al.
The Journal of Sexual Medicine|October 11, 2011
Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind studyRussell Blair Egerdie, Stephen Auerbach, Claus G Roehrborn, et al.
American Journal of Obstetrics and Gynecology|February 20, 2003
Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal womenValerie P Jackson, Javier A San Martin, Roberta J Secrest, et al.
Journal of Patient-Reported Outcomes|November 1, 2019
A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitisLouise Newton, Jason A Randall, Theresa Hunter, et al.
Lower Urinary Tract Symptoms|December 18, 2015
Tadalafil Administered Once Daily for Treatment of Lower Urinary Tract Symptoms in Korean men with Benign Prostatic Hyperplasia: Results from a Placebo-Controlled Pilot Study Using Tamsulosin as an Active ControlSae Chul Kim, Jong Kwan Park, Sae Woong Kim, et al.
Lancet (London, England)|June 15, 2015
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trialsChristopher E M Griffiths, Kristian Reich, Mark Lebwohl, et al.
The New England Journal of Medicine|June 15, 2016
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque PsoriasisKenneth B Gordon, Andrew Blauvelt, Kim A Papp, et al.
Physical Review Letters|October 26, 2005
Q2 dependence of the neutron spin structure function g2(n) at low Q2K Kramer, D S Armstrong, T D Averett, et al.
Physical Review Letters|October 13, 2007
Transverse beam spin asymmetries in forward-angle elastic electron-proton scatteringD S Armstrong, J Arvieux, R Asaturyan, et al.
Pageof 4